
BetterMe Rx
Flexible GLP-1 treatment formats with online medical guidance and multiple subscription options.
Starting Price
Semaglutide injection: $99 per month on a 12-month plan
One-month option; longer plan rates and upfront commitments differ.BUYERS GUIDE · Health & Wellness / Weight Management
Compare semaglutide and tirzepatide options, pricing, medical support, and subscription terms across six online weight loss providers.
Medical review: Not medically reviewed

GLP-1 medications have become an increasingly popular option for medical weight management. Two commonly discussed medications are semaglutide and tirzepatide, which help regulate appetite and blood sugar. Semaglutide works by activating GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP receptors. Both have demonstrated clinically meaningful weight loss in clinical trials.
Semaglutide is the active ingredient in FDA-approved medications such as Ozempic and Wegovy, while tirzepatide is the active ingredient in Mounjaro and Zepbound. However, compounded versions offered through some online providers are not the same as these FDA-approved brand-name medications and have not been reviewed or approved by the FDA.
As more online healthcare providers offer access to GLP-1 treatments, choosing between them can be confusing. Even when providers offer medications containing the same active ingredients, their pricing, medication sourcing, medical support, and subscription terms can vary considerably.
In this guide, we compare six online GLP-1 providers: BetterMe Rx, Refills, HumeCare+, Gala, MedVi, and DirectMeds. We'll explore their medication options, pricing structures, medical services, and key differences to help you make a more informed decision.
Starting prices are not directly equivalent. Review billing periods, upfront commitments and what is included.

Flexible GLP-1 treatment formats with online medical guidance and multiple subscription options.
Semaglutide injection: $99 per month on a 12-month plan
One-month option; longer plan rates and upfront commitments differ.
Personalized online weight management with clinician-guided treatment and ongoing refill support.
Semaglutide: $99 per month
No hidden fees. No monthly membership. Cancel anytimeTirzepatide: $159 per month
No hidden fees. No monthly membership. Cancel anytime
Physician-guided GLP-1 care combined with body composition tracking and personalized support.
Oral treatment program: $7 Introductory offer from $7 /Day
Automatic refills - cancel anytime. 180 days Money Back Promise
Online GLP-1 treatment with bundled pricing, medical oversight, and multiple medication options.
Compounded semaglutide from: $69 per month on an annual plan
Annual plan, billed once a year. Exact quote depends on state, dose and selected plan.Compounded tirzepatide from: $99 per month on an annual plan
Annual plan, billed once a year. Confirm the full prepaid total, cancellation and refund terms.
Online weight management with multiple medication pathways and access to clinical support.
Compounded semaglutide injection: $116 per month
Starting at $116/monthCompounded tirzepatide injection: $166 per month
Starting at $166/month
Convenient online GLP-1 prescribing with home delivery and ongoing provider support.
Semaglutide: $69 per month
Month-to-month and prepaid multi-month plans available. Monthly subscriptions are generally billed every 28 days.Tirzepatide: $119 per month
Month-to-month and prepaid multi-month plans available. Monthly subscriptions are generally billed every 28 days.BetterMe Rx is an online weight management service offering access to prescription-based GLP-1 treatments through a virtual care process. Its advertised programs include injectable medications and selected oral treatment options, with different subscription lengths available.
BetterMe Rx offers several treatment and subscription pathways, making it relevant for customers who want flexibility in how they approach online weight management. Its longer-term pricing may be appealing, but the total financial commitment and exact medication formulation deserve careful consideration.
Refills is a telehealth platform connecting patients with independent licensed healthcare providers for personalized weight management. Its programs include virtual consultations, prescription coordination, and ongoing support designed to help eligible patients manage their treatment remotely
Refills focuses on making ongoing weight management easier to coordinate through virtual care and prescription support. Its service model may appeal to customers who value convenience and continuity. However, transparent medication sourcing, complete pricing information, and regulatory history are important considerations when evaluating the platform.
HumeCare+ combines prescription-based weight management with body composition monitoring and ongoing clinical guidance. Its program incorporates medication-related services, progress tracking, and access to the Hume Health ecosystem, with an emphasis on monitoring changes in body fat and lean mass.
HumeCare+ offers a distinctive approach by incorporating body composition monitoring into its weight management experience. This may interest customers who want to track changes beyond body weight alone. However, its tracking features should be evaluated separately from medication effectiveness, and the value of the program depends on which services are actually included.
Gala is an online healthcare platform offering prescription weight management alongside other medical services. Its advertised GLP-1 programs include semaglutide and tirzepatide treatment options, with virtual medical evaluations, prescription coordination, and home delivery services.
Gala is notable for its advertised entry-level pricing and bundled treatment structure. Its longer-term plans may be worth comparing for customers who are comfortable with an extended financial commitment. However, the advertised monthly-equivalent price is only one part of the decision, and the full payment terms and medication sourcing deserve equal attention.
MedVi is an online weight management platform connecting eligible patients with prescription treatment pathways through a virtual medical evaluation process. Its advertised offerings have included semaglutide and tirzepatide programs, along with patient support and prescription coordination services.
Introductory pricing may differ from ongoing treatment costs, and some plans may include additional fees. Customers should verify medication sourcing, renewal pricing, and cancellation terms. Compounded medications are not FDA-approved. The FDA issued MEDVi a warning letter in February 2026 regarding misleading representations of compounded medications. Customers should review any subsequent regulatory updates before enrolling.
DirectMeds is an online weight management platform offering access to prescription treatment programs through licensed healthcare providers. Its services include virtual medical evaluations, prescription coordination, home delivery, and ongoing support, with an emphasis on simplifying access to treatment.
DirectMeds emphasizes simplicity, remote access, and home delivery, making it relevant for customers who prioritize convenience. Its promotional pricing may attract attention, but comparing the full treatment cost and subscription conditions is more useful than relying on introductory offers alone. Medication sourcing and clinical oversight should also be part of the decision.
Start with the total cost. Request the amount due now, the full treatment term, renewal charge and any consultation, shipping or follow-up fees. Introductory offers and annual-plan equivalents should not be treated as interchangeable monthly subscriptions.
Identify the exact medication and formulation. FDA-approved medicines and compounded preparations are not the same regulatory category. FDA does not review compounded products for safety, effectiveness or quality before marketing. Check current FDA information and discuss lawful, appropriate options with a licensed clinician.
Ask who reviews your medical history, how to contact a clinician and what happens if the treatment is unsuitable. Oral and injectable products are not automatically interchangeable; suitability depends on the actual product and clinical evaluation.
Read cancellation and renewal terms before paying, especially for prepaid plans. Confirm state availability, pharmacy details, refund eligibility and ongoing support in writing. Do not rely on a provider’s marketing to predict an individual health outcome.
There is no supported overall winner here. The appropriate shortlist depends on the treatment a licensed clinician considers suitable, the actual billing commitment and the support you need. Compare written quotes for equivalent treatment terms rather than ranking unlike starting figures.
Use the provider links to inspect current terms, then review the medication and care arrangements with a qualified healthcare professional. If important costs or clinical details remain unclear, resolve them before enrolling.
We have not independently tested these programs or verified patient outcomes. This comparison draws on the provider information and sources listed below. Pricing and medical-content verification notes remain unresolved until editorial review.
— Initial publication. Compared six GLP-1 telehealth providers, including treatment options, advertised pricing, billing terms, and key considerations for choosing a provider.
ThisDealSlaps may receive compensation when readers complete qualifying enrollments or purchases through affiliate links. Some featured providers may have commercial relationships with our affiliate business. Our comparisons focus on pricing, features, and practical considerations. We have not independently tested these programs or verified patient outcomes.
Some services arrange online evaluations with licensed clinicians. A prescription requires an appropriate evaluation and depends on medical eligibility, location and the actual medication. Completing an enrollment form does not guarantee a prescription.
No. Compounded medications are not FDA-approved. FDA does not review their safety, effectiveness or quality before marketing. Do not assume that a compounded product has the same evidence or regulatory status as an approved brand-name medicine.
A reliable answer requires comparable written quotes. The figures here include different billing periods and commitments, and some remain under verification. Compare the total upfront and renewal costs for the exact treatment and term; the smallest headline figure is not necessarily the lowest total cost.
Insurance requirements and payment options vary by program and treatment. Some provider pages describe self-pay enrollment without insurance. Confirm coverage, payment eligibility and all out-of-pocket costs directly with your selected program.
Programs generally begin with medical-history information and an eligibility review. The clinician may use messaging, video or another permitted format depending on the service, treatment and state requirements. Ask how follow-up and urgent questions are handled.
Ozempic is a brand-name prescription medication containing semaglutide, a GLP-1 receptor agonist. It is FDA-approved for treating type 2 diabetes and certain related risk-reduction indications, but it is not specifically approved for weight loss.
Wegovy also contains semaglutide but is approved for chronic weight management in eligible patients. Although Ozempic and Wegovy share the same active ingredient, their approved uses, dosing schedules, and available formulations differ.
Other medications, such as Zepbound (tirzepatide), work differently by targeting both GIP and GLP-1 receptors.
Compounded semaglutide products offered through some telehealth providers are not FDA-approved and should not be assumed to be interchangeable with Ozempic or Wegovy.
The most appropriate treatment depends on a patient's medical history, eligibility, and a clinician's assessment.
This content is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Prescription medications require an appropriate clinical evaluation. Compounded medications are not FDA-approved. Consult a licensed healthcare professional about your individual circumstances.